Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $5.4500 (6.24%) ($5.4500 - $5.4500) on Tue. Mar. 9, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.75% (three month average) | RSI | 31 | Latest Price | $5.4500(6.24%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -1.3% a day on average for past five trading days. | Weekly Trend | CAPR declines -12.8% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) XLV(98%) XLK(82%) XME(67%) DIA(66%) ONLN(58%) | Factors Impacting CAPR price | CAPR will decline at least -3.875% in a week (0% probabilities). OIH(-21%) USO(-12%) UNG(-4%) VXX(-21%) PEJ(-24%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.875% (StdDev 7.75%) | Hourly BBV | 1.4 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-19.53(-458.35%) | Resistance Level | $6.47 | 5 Day Moving Average | $5.33(2.25%) | 10 Day Moving Average | $5.71(-4.55%) | 20 Day Moving Average | $6.47(-15.77%) | To recent high | -31.4% | To recent low | 6.9% | Market Cap | $107m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |